Advantages of visualisations to evaluate and communicate adverse event information in randomised controlled trials
Abstract Background Randomised controlled trials (RCTs) provide valuable information and inform the development of harm profiles of new treatments. Harms are typically assessed through the collection of adverse events (AEs). Despite AEs being routine outcomes collected in trials, analysis and report...
Main Authors: | Victoria Cornelius, Suzie Cro, Rachel Phillips |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-12-01
|
Series: | Trials |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13063-020-04903-0 |
Similar Items
-
Statistical methods for the analysis of adverse event data in randomised controlled trials: a scoping review and taxonomy
by: Rachel Phillips, et al.
Published: (2020-11-01) -
Improving analysis practice of continuous adverse event outcomes in randomised controlled trials - a distributional approach
by: Anca Chis Ster, et al.
Published: (2021-06-01) -
Identification, collection, and reporting of harms among non-industry-sponsored randomized clinical trials of pharmacologic interventions in the critically ill population: a systematic review
by: Ari Moskowitz, et al.
Published: (2020-07-01) -
Adverse Event Burden Score—A Versatile Summary Measure for Cancer Clinical Trials
by: Jennifer G. Le-Rademacher, et al.
Published: (2020-11-01) -
Joint modelling of multivariate longitudinal clinical laboratory safety outcomes, concomitant medication and clinical adverse events: application to artemisinin-based treatment during pregnancy clinical trial
by: Noel Patson, et al.
Published: (2021-10-01)